- Home
- DXCM vs ROP Comparison
DXCM vs ROP Comparison
Compare DXCM & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXCM | ROP |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.4B | 34.1B |
| IPO Year | 2005 | 2002 |
Fundamental Metrics
Financial Performance| Metric | DXCM | ROP |
|---|---|---|
| Price | $87.32 | $382.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 29 | 19 |
| Target Price | $96.46 | ★ $439.43 |
| AVG Volume (30 Days) | ★ 3.5M | 788.2K |
| Earning Date | 10-29-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ 47.18 | N/A |
| EPS | 1.15 | ★ 16.35 |
| Revenue | N/A | ★ $7,902,500,000.00 |
| Revenue This Year | $12.17 | $8.29 |
| Revenue Next Year | $10.78 | $6.23 |
| P/E Ratio | $72.60 | ★ $22.78 |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $54.11 | $305.96 |
| 52 Week High | $92.59 | $519.10 |
Technical Indicators
Market Signals| Indicator | DXCM | ROP |
|---|---|---|
| Relative Strength Index (RSI) | 55.32 | 58.65 |
| Support Level | $87.51 | $343.77 |
| Resistance Level | $91.77 | $408.02 |
| Average True Range (ATR) | 2.12 | 6.79 |
| MACD | -0.01 | 3.49 |
| Stochastic Oscillator | 96.22 | 90.39 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
About ROP Roper Technologies Inc.
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.